eglumetad has been researched along with Catatonic Rigidity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konieczny, J; Ossowska, K; Pilc, A; Wolfarth, S | 1 |
| Konieczny, J; Lorenc-Koci, E; Ossowska, K; Pilc, A; Wolfarth, S | 1 |
2 other study(ies) available for eglumetad and Catatonic Rigidity
| Article | Year |
|---|---|
LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.
Topics: Animals; Antiparkinson Agents; Bridged Bicyclo Compounds; Excitatory Amino Acid Agonists; Haloperidol; Male; Muscle Rigidity; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate | 1998 |
The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity.
Topics: Animals; Bridged Bicyclo Compounds; Electromyography; Glycine; Ligands; Male; Muscle Rigidity; Parkinson Disease; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate | 2000 |